Design and synthesis of 2-quinolones as antioxidants and antimicrobials: a rational approach

被引:60
作者
Jayashree, B. S. [1 ]
Thomas, Seeja [1 ]
Nayak, Yogendra [2 ]
机构
[1] Manipal Coll Pharmaceut Sci, Dept Pharmaceut Chem, Manipal 576104, Karnataka, India
[2] Manipal Coll Pharmaceut Sci, Dept Pharmacol, Manipal 576104, Karnataka, India
关键词
Antibacterial; Antioxidant; Carboxamides; Docking simulations; QSAR analysis; 2-Quinolones; DNA GYRASE; BINDING-SITE; DERIVATIVES; INHIBITORS; RECEPTOR; GLYCINE;
D O I
10.1007/s00044-009-9184-x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As an important class of compounds, 2-quinolones are isomeric to 4-quinolones and isosteric to coumarins. The compounds that have 2-quinolone moiety are associated with interesting biologic activities such as antibacterial, anticancer, antiviral, cardiotonic, and N-methyl-D-aspartate receptor inhibitor functions, among others. In the current study, based on the rational approach, lead molecules of the 2-quinolone skeleton were designed for binding to the bacterial DNA gyrase subunit A. Docking simulations and quantitative structure activity relationship (QSAR) analysis were performed using the Molegro Virtual Docker and Sarchitech softwares. Based on these studies, the 7-amino-4-methylquinolin-2(1H)-one parent compound and its carboxamides (JST 1-15) were synthesized using Conrad Limpach synthesis. The synthesized test compounds then were characterized by thin-layer chromatography and melting point determination, as well as by ultraviolet, infrared (IR), (1)H-NMR, and MS studies. All synthesized and purified compounds were tested for antioxidant and antibacterial activity.
引用
收藏
页码:193 / 209
页数:17
相关论文
共 22 条
[1]  
BECKETT AH, 2005, PRACTICAL PHARM CH 2, P275
[2]   Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening [J].
Boehm, HJ ;
Boehringer, M ;
Bur, D ;
Gmuender, H ;
Huber, W ;
Klaus, W ;
Kostrewa, D ;
Kuehne, H ;
Luebbers, T ;
Meunier-Keller, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2664-2674
[3]   Effect of different classes of inhibitors on DNA gyrase from Mycobacterium smegmatis [J].
Chatterji, M ;
Unniraman, S ;
Mahadevan, S ;
Nagaraja, V .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (04) :479-485
[4]   PREPARATION AND INVITRO AND INVIVO EVALUATION OF QUINOLONES WITH SELECTIVE ACTIVITY AGAINST GRAM-POSITIVE ORGANISMS [J].
COOPER, CS ;
KLOCK, PL ;
CHU, DTW ;
HARDY, DJ ;
SWANSON, RN ;
PLATTNER, JJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (08) :1392-1398
[5]  
CRUICKSHANK R, 1975, MED MICROBIOLOGY, V2, P190
[6]  
Danysz W, 1998, PHARMACOL REV, V50, P597
[7]  
Dodia Narsinh, 2001, Indian Journal of Pharmaceutical Sciences, V63, P211
[8]  
FURNISS BS, 2004, VOGELS TXB PRACTICAL, P1074
[9]   Quinolone-binding pocket of DNA gyrase: Role of GyrB [J].
Heddle, J ;
Maxwell, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1805-1815
[10]   Alkaloids from Toddalia aculeata [J].
Jain, Subhash C. ;
Pandey, Mukesh K. ;
Upadhyay, Ravi K. ;
Kumar, Rohtash ;
Hundal, Geeta ;
Hundal, Maninder S. .
PHYTOCHEMISTRY, 2006, 67 (10) :1005-1010